Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

In Jim Cramer's "Stop Trading" segment on CNBC's Squawk on the Street program, the famous stock picker mentioned Amgen ...

2025 Revenue Guidance -- Management expects full-year revenue of $30 million to $40 million, with Q4 guidance of $5 million ...

As it turns out, select Wall Street analysts believe that these two stocks could gain at least 20% over the next year.

Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...

Record Revenue -- $14.2 million, up 35% year-over-year and 15% sequentially from Q2 2025. Recurring Revenue -- $6.5 million ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Ballast Asset Management trimmed its Solaris Energy Infrastructure (SEI) position in Q3, locking in some gains after the ...

Webtoon's revenue rose by 8.7% year over year to $378 million, fueled by new storytelling formats and successful adaptations ...

Shares of On Holding ( ONON +2.14%) shot up over 20% this week, according to data from S&P Global Market Intelligence. The ...

Trailing Twelve-Month Core Product Sales -- $37 million, a company record, up from $33.8 million, with distributor and ...

Barington Companies Management established a new equity position in BILL Holdings, adding 65,000 shares valued at $3.44 ...